Search results for "Prostate cancer"
Catheters, infusion pumps recalled
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/02/catheters-infusion-pumps-recalled.htm
1 Feb 2021
More patients undergoing active surveillance for lower-risk prostate cancers
Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
https://immattersacp.org/weekly/archives/2023/04/11/4.htm
11 Apr 2023
Decision aids increased knowledge about prostate cancer but didn't affect screening rates
Decision aids improved participants' informed decision making about prostate cancer screening but did not change the actual screening rates, a study found.
https://immattersacp.org/weekly/archives/2013/08/06/2.htm
6 Aug 2013
Decision aids integral to shared decision making
When used properly and in the correct situation, decision aids save time and costs by better meeting patient needs and increasing adherence.
https://immattersacp.org/archives/2019/05/decision-aids-integral-to-shared-decision-making.htm
1 May 2019
Age, comorbidity should inform decisions on how to treat low- or intermediate- risk prostate cancer
Older men with prostate cancer and multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this when deciding between conservative management and aggressive treatment for low- or intermediate-risk disease, a study concluded.
https://immattersacp.org/weekly/archives/2013/05/21/2.htm
21 May 2013
In the News
New opioid therapy guidelines released; PFO closure may help migraines.
https://immattersacp.org/archives/2009/04/in-the-news.htm
1 Apr 2009
Studies find rates of PSA screening, incidence of early-stage prostate cancer declining
An editorial called for personalized screening strategies that are tailored to a man's individual risk and preferences.
https://immattersacp.org/weekly/archives/2015/11/24/1.htm
24 Nov 2015
Treatment for prostate symptoms doesn't appear to increase risk for advanced prostate cancer
Treating prostate symptoms with 5α-reductase inhibitors (5-ARIs) does not appear to increase risk for advanced prostate cancer, a new study indicates.
https://immattersacp.org/weekly/archives/2013/06/25/1.htm
25 Jun 2013
NAFLD treatment starts with weight loss, then other modes
Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016
Cancer society recommends prostate cancer specialists team with primary care physicians to coordinate survivorship care
Prostate cancer specialists should ensure a patient's primary care clinician is included as part of the post-treatment clinical follow-up team, a new guideline stated.
https://immattersacp.org/weekly/archives/2014/06/17/1.htm
17 Jun 2014